While the most recent guidelines of the European Association of Urology (EAU) support the use of PSMA PET/CT imaging for biochemical recurrence of PCa after radical prostatectomy, they remain elusive regarding its use in primary staging (Mottet et al. 2022). The gene discussed is FOLH1; the disease is posterior cortical atrophy.